Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01773746 · ClinicalTrials.gov registry record · NA

Study of Room Air Versus 60% Oxygen for Resuscitation of Premature Infants

A NA study, sponsored by Sharp HealthCare.

Terminated
Registry status
NA
Development phase
80
Enrollment target

NCT01773746: Clinical Trial NA study, sponsored by Sharp HealthCare.

NCT01773746 is a NA study that was terminated before completion, run by Sharp HealthCare. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01773746, a NA study, was terminated before completion, sponsored by Sharp HealthCare.

TERMINATED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

The most appropriate initial oxygen concentration for the resuscitation of the extremely low birth weight infant has not been established using large well designed, randomized, blinded, prospective trials and the level of oxygen utilized by practitioners in this situation is highly variable. This proposed trial will use targeted oxygen saturation levels over the first 15 to 20 minutes of life to compare a low and a higher initial oxygen level for the resuscitation of such infants, and will be large enough to evaluate short term outcomes of survival without oxygen at 36 weeks and survival without retinopathy of prematurity, and the long term outcome of survival without significant neurodevelopmental impairment at 2 years of age. Such information is urgently required to provide an evidence basis for the initial oxygen concentration for resuscitation of these very preterm infants.

Interventions

  • OTHER Neonatal Resuscitation

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2013-08
Est. Completion 2017-03-01
Phase NA

Sponsor

Sharp HealthCare

32 total trials

What the Registry Record Tells You About NCT01773746

The ClinicalTrials.gov registry entry for NCT01773746 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sharp HealthCare, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Neonatal Resuscitation is the first listed.

NCT01773746 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01773746 about?

NCT01773746 is a clinical study titled "Study of Room Air Versus 60% Oxygen for Resuscitation of Premature Infants". The most appropriate initial oxygen concentration for the resuscitation of the extremely low birth weight infant has not been established using large well designed, randomized, blinded, prospective trials and the level of oxygen utilized by practitioners in this situation is highly variable. This pr...

What is the current status of trial NCT01773746?

This trial is currently terminated. It is a NA study. The enrollment target is 80 participants. The study started on 2013-08. Estimated completion is 2017-03-01.

What interventions are being tested in trial NCT01773746?

The interventions under investigation include: Neonatal Resuscitation (OTHER).

Who is sponsoring clinical trial NCT01773746?

This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.